Wockhardt US unit gets FDA warning notePost published:March 1, 2017Post category:Industry NewsProducts of Wockhardt’s US unit Morton Grove Pharma will be available in that market but new approvals will be withheld until compliance issues are resolved Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostMasterCard eyes 1 million traders on its BharatQR platform Next PostYahoo chief counsel exits after hack probe finds inaction You Might Also Like There is no other market with the RoE profile of India: Vikas Khemani September 1, 2017 The Battery Management System (BMS) and its Evolution December 16, 2019 Robots Don’t Kill Jobs, They Automate Tasks April 24, 2019